SPAID: a comprehensive database for disease-specific autoantigens in autoimmune disorders.

Shunhui Deng, Fangfang Wei, Ya Pang, Luowanyue Zhang, Shengyao Zhi, Tianjian Chen, Zhixiang Zuo, Jian Ren, Yubin Xie, Xiaotong Luo
{"title":"SPAID: a comprehensive database for disease-specific autoantigens in autoimmune disorders.","authors":"Shunhui Deng, Fangfang Wei, Ya Pang, Luowanyue Zhang, Shengyao Zhi, Tianjian Chen, Zhixiang Zuo, Jian Ren, Yubin Xie, Xiaotong Luo","doi":"10.1007/s44307-026-00117-8","DOIUrl":null,"url":null,"abstract":"<p><p>Autoimmune diseases (ADs) are chronic inflammatory disorders characterized by complex etiologies and significant diagnostic challenges. Although autoantigens are critical for precision diagnosis and therapy, much of the immunogenic landscape remains unexplored due to the historical focus on canonical proteins. Here, we developed SPAID ( https://spaid.renlab.cn ), a comprehensive resource for candidate autoantigen discovery across 14 ADs that integrates canonical and non-canonical proteins within a two-level evidence framework. The validated level contains proteins associated with experimentally confirmed epitopes from T-cell assays and major histocompatibility complex (MHC) ligand assays. The proteomics-based level contains proteins identified by mass spectrometry (MS) from human samples, further annotated with differential expression patterns, immunogenicity scores, and functional features to support candidate autoantigen discovery and further validation. By combining validated evidence with proteomics-based evidence, SPAID enables the comprehensive characterization of candidate autoantigen repertoires and facilitates mechanistic investigation into antigen origins and pathogenic recognition. Overall, SPAID provides a foundational resource for advancing antigen-centered research and developing novel diagnostic and therapeutic strategies in autoimmunity.</p>","PeriodicalId":519913,"journal":{"name":"Advanced biotechnology","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13246995/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s44307-026-00117-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Autoimmune diseases (ADs) are chronic inflammatory disorders characterized by complex etiologies and significant diagnostic challenges. Although autoantigens are critical for precision diagnosis and therapy, much of the immunogenic landscape remains unexplored due to the historical focus on canonical proteins. Here, we developed SPAID ( https://spaid.renlab.cn ), a comprehensive resource for candidate autoantigen discovery across 14 ADs that integrates canonical and non-canonical proteins within a two-level evidence framework. The validated level contains proteins associated with experimentally confirmed epitopes from T-cell assays and major histocompatibility complex (MHC) ligand assays. The proteomics-based level contains proteins identified by mass spectrometry (MS) from human samples, further annotated with differential expression patterns, immunogenicity scores, and functional features to support candidate autoantigen discovery and further validation. By combining validated evidence with proteomics-based evidence, SPAID enables the comprehensive characterization of candidate autoantigen repertoires and facilitates mechanistic investigation into antigen origins and pathogenic recognition. Overall, SPAID provides a foundational resource for advancing antigen-centered research and developing novel diagnostic and therapeutic strategies in autoimmunity.

SPAID:自身免疫性疾病中疾病特异性自身抗原的综合数据库。
自身免疫性疾病(ADs)是一种慢性炎症性疾病,其病因复杂,诊断困难。尽管自身抗原对精确诊断和治疗至关重要,但由于历史上对典型蛋白的关注,许多免疫原性领域仍未得到探索。在这里,我们开发了SPAID (https://spaid.renlab.cn),这是一个在14个ad中发现候选自身抗原的综合资源,在两级证据框架内整合了规范和非规范蛋白。经过验证的水平含有与实验证实的表位相关的蛋白质,这些表位来自t细胞测定和主要组织相容性复合体(MHC)配体测定。基于蛋白质组学的水平包含从人类样本中通过质谱(MS)鉴定的蛋白质,进一步用差异表达模式、免疫原性评分和功能特征进行注释,以支持候选自身抗原的发现和进一步验证。通过将验证证据与基于蛋白质组学的证据相结合,SPAID能够全面表征候选自身抗原库,并促进抗原起源和病原识别的机制研究。总的来说,SPAID为推进以抗原为中心的研究和开发新的自身免疫诊断和治疗策略提供了基础资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书